Sign Out
Hytrin (terazosin hydrochloride) is indicated for the relief of the manifestations of mild to moderate benign prostatic hyperplasia (BPH). Treatment should be stopped if patients have not responded after three months of therapy.
Terazosin is also indicated in the treatment of hypertension. It can be used alone or in combination with other antihypertensive agents such as diuretics or beta-adrenergic blocking agents.
